Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:ganirelix
|
| gptkbp:approvedBy |
2000
|
| gptkbp:ATCCode |
H01CA02
|
| gptkbp:CASNumber |
gptkb:123246-29-7
|
| gptkbp:chemicalFormula |
C82H103ClN18O16
|
| gptkbp:contraindication |
pregnancy
lactation hypersensitivity to ganirelix |
| gptkbp:eliminationHalfLife |
13-16 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Orgalutran
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_Sharp_&_Dohme
|
| gptkbp:mechanismOfAction |
GnRH antagonist
|
| gptkbp:pregnancyCategory |
Category X (contraindicated)
|
| gptkbp:prevention |
premature luteinizing hormone surges
|
| gptkbp:proteinBinding |
78%
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
nausea
abdominal pain headache injection site reactions |
| gptkbp:synonym |
gptkb:ganirelix_acetate
|
| gptkbp:usedFor |
in vitro fertilization
assisted reproduction |
| gptkbp:bfsParent |
gptkb:MRK
|
| gptkbp:bfsLayer |
5
|